ALGN vs. STE, ZBH, SNN, MSA, ESTA, AVNS, INGN, EW, ARGX, and WAT
Should you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include STERIS (STE), Zimmer Biomet (ZBH), Smith & Nephew (SNN), MSA Safety (MSA), Establishment Labs (ESTA), Avanos Medical (AVNS), Inogen (INGN), Edwards Lifesciences (EW), argenx (ARGX), and Waters (WAT).
STERIS (NYSE:STE) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.
Align Technology received 441 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 69.64% of users gave Align Technology an outperform vote while only 58.51% of users gave STERIS an outperform vote.
Align Technology has a net margin of 11.80% compared to Align Technology's net margin of 6.95%. STERIS's return on equity of 14.15% beat Align Technology's return on equity.
Align Technology has lower revenue, but higher earnings than STERIS. Align Technology is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
STERIS has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.66, meaning that its stock price is 66% more volatile than the S&P 500.
94.7% of STERIS shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 1.0% of STERIS shares are held by insiders. Comparatively, 0.6% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, STERIS had 4 more articles in the media than Align Technology. MarketBeat recorded 14 mentions for STERIS and 10 mentions for Align Technology. STERIS's average media sentiment score of 1.03 beat Align Technology's score of 0.77 indicating that Align Technology is being referred to more favorably in the news media.
STERIS presently has a consensus price target of $241.60, suggesting a potential upside of 3.83%. Align Technology has a consensus price target of $353.00, suggesting a potential upside of 30.02%. Given STERIS's higher probable upside, analysts clearly believe Align Technology is more favorable than STERIS.
Summary
Align Technology beats STERIS on 12 of the 17 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding ALGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Align Technology Competitors List
Related Companies and Tools
